MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES
At present experimental and clinical data confirming efficacy of magnesium-containing drugs in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its intracellular fraction. That is why it is desirable to use magnesium with the components contrib...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/471 |
| _version_ | 1797232373838905344 |
|---|---|
| author | A. V. Govorin A. P. Filev |
| author_facet | A. V. Govorin A. P. Filev |
| author_sort | A. V. Govorin |
| collection | DOAJ |
| description | At present experimental and clinical data confirming efficacy of magnesium-containing drugs in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its intracellular fraction. That is why it is desirable to use magnesium with the components contributing to its intracellular penetration. Magnerot deserves attention as a complex drug consisting of magnesium and orotic acid that contributes to intracellular penetration. Data of some studies on magnesium-containing drugs application in different cardiovascular diseases are presented. |
| first_indexed | 2024-03-08T14:04:58Z |
| format | Article |
| id | doaj.art-5c384769ec204675a11e060a33a3c14c |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:59:15Z |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-5c384769ec204675a11e060a33a3c14c2024-04-01T07:43:26ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-018346346810.20996/1819-6446-2012-8-3-463-468471MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASESA. V. Govorin0A. P. Filev1Chita State Medical AcademyChita State Medical AcademyAt present experimental and clinical data confirming efficacy of magnesium-containing drugs in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its intracellular fraction. That is why it is desirable to use magnesium with the components contributing to its intracellular penetration. Magnerot deserves attention as a complex drug consisting of magnesium and orotic acid that contributes to intracellular penetration. Data of some studies on magnesium-containing drugs application in different cardiovascular diseases are presented.https://www.rpcardio.online/jour/article/view/471magnesiumorotic acidmagnerotcardiovascular system |
| spellingShingle | A. V. Govorin A. P. Filev MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Рациональная фармакотерапия в кардиологии magnesium orotic acid magnerot cardiovascular system |
| title | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
| title_full | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
| title_fullStr | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
| title_full_unstemmed | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
| title_short | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
| title_sort | magnesium containing drugs in cardiovascular diseases |
| topic | magnesium orotic acid magnerot cardiovascular system |
| url | https://www.rpcardio.online/jour/article/view/471 |
| work_keys_str_mv | AT avgovorin magnesiumcontainingdrugsincardiovasculardiseases AT apfilev magnesiumcontainingdrugsincardiovasculardiseases |